LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

Search

Schrodinger Inc

Затворен

СекторЗдравеопазване

14.15 -2.35

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

13.91

Максимум

14.62

Ключови измерители

By Trading Economics

Приходи

-196M

-60M

Продажби

-29M

59M

EPS

-0.62

Марж на печалбата

-102.456

Служители

850

EBITDA

-85M

-49M

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+30.56% upside

Дивиденти

By Dow Jones

Следващи печалби

5.08.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

111M

1.1B

Предишно отваряне

16.5

Предишно затваряне

14.15

Настроения в новините

By Acuity

60%

40%

276 / 344 Класиране в Healthcare

Schrodinger Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

10.06.2026 г., 23:36 ч. UTC

Печалби

Correction to Oracle Reports Higher 4Q Profit Article

10.06.2026 г., 23:19 ч. UTC

Горещи акции

Stocks to Watch: Oracle, Oxford Industries, Humacyte, PureCycle Technologies

10.06.2026 г., 23:09 ч. UTC

Значими двигатели на пазара

PureCycle Technologies Slides on Offerings of Stock and Convertible Notes

10.06.2026 г., 23:04 ч. UTC

Печалби

Oracle Reports Higher 4Q Profit on Surging Cloud Revenue -- Update

10.06.2026 г., 20:44 ч. UTC

Значими двигатели на пазара

Caterpillar Raises Quarterly Dividend 8%

10.06.2026 г., 23:49 ч. UTC

Придобивния, сливания и поглъщания

Elliott: Northern Star Should Take No Options Off The Table

10.06.2026 г., 23:48 ч. UTC

Придобивния, сливания и поглъщания

Elliott: Reiterates Call For Formal Strategic Review of Northern Star

10.06.2026 г., 23:48 ч. UTC

Придобивния, сливания и поглъщания

Elliott: Northern Star Board Must Be Substantially Strengthened Beyond 1 Additional Director

10.06.2026 г., 23:47 ч. UTC

Пазарно говорене

Nintendo's Stock Recovery Likely Deferred Without Mario Game -- Market Talk

10.06.2026 г., 23:47 ч. UTC

Придобивния, сливания и поглъщания

Elliott: Board Letter Indicates It Doesn't Understand Magnitude of Change Required

10.06.2026 г., 23:46 ч. UTC

Придобивния, сливания и поглъщания

Elliott Investment Management: Northern Star Letter Validates Investment Thesis

10.06.2026 г., 23:38 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

10.06.2026 г., 23:38 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

10.06.2026 г., 23:38 ч. UTC

Пазарно говорене

Nikkei Likely to Fall on Renewed Concerns About Iran Conflict -- Market Talk

10.06.2026 г., 23:32 ч. UTC

Пазарно говорене

Oil Rises Amid Escalating Supply-Disruption Fears -- Market Talk

10.06.2026 г., 23:20 ч. UTC

Пазарно говорене

Wesfarmers's Bunnings Business Looks Resilient to Macro Headwinds -- Market Talk

10.06.2026 г., 22:05 ч. UTC

Пазарно говорене

Correction to Bank of Canada Stays on Hold Market Talk

10.06.2026 г., 21:57 ч. UTC

Печалби

Oracle Stock Slides on Mixed Earnings. Software Is an Issue. -- Barrons.com

10.06.2026 г., 21:52 ч. UTC

Печалби

Oracle Stock Slides on Mixed Earnings. Software Is an Issue. -- Barrons.com

10.06.2026 г., 21:35 ч. UTC

Печалби

Oracle Stock Slides on Mixed Earnings. Software Is an Issue. -- Barrons.com

10.06.2026 г., 21:22 ч. UTC

Печалби

Oracle Stock Slides on Increased Capital Spending -- WSJ

10.06.2026 г., 20:50 ч. UTC

Пазарно говорене
Печалби

Tech, Media & Telecom Roundup: Market Talk

10.06.2026 г., 20:50 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

10.06.2026 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

10.06.2026 г., 20:50 ч. UTC

Пазарно говорене

Health Care Roundup: Market Talk

10.06.2026 г., 20:39 ч. UTC

Пазарно говорене
Печалби

Oracle Needs to Raise Less Capital to Fund Data-Center Buildout -- Market Talk

10.06.2026 г., 20:34 ч. UTC

Печалби

Oracle Stock Slides on Mixed Earnings. Software Is an Issue. -- Barrons.com

10.06.2026 г., 20:33 ч. UTC

Печалби

This 'Amazon for Travel' Firm Beat Earnings Expectations. The Stock Is Soaring. -- Barrons.com

10.06.2026 г., 20:33 ч. UTC

Пазарно говорене
Печалби

Global Equities Roundup: Market Talk

10.06.2026 г., 20:33 ч. UTC

Пазарно говорене
Печалби

Oracle Health Expected to Grow Double-Digits This Fiscal Year -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

Schrodinger Inc Прогноза

Ценова цел

By TipRanks

30.56% нагоре

12-месечна прогноза

Среден 18.8 USD  30.56%

Висок 24 USD

Нисък 13 USD

Според 7 анализатори от Wall Street, предложили 12-месечна ценова цел за Schrodinger Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

7 ratings

5

Купи

2

Задържане

0

Продай

Настроение

By Acuity

276 / 344 Класиране в Здравеопазване

Настроения в новините

Мечи доказателства

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Schrodinger Inc

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. It has a research collaboration and license agreement with Novartis AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
help-icon Live chat